Results 151 to 160 of about 138,873 (259)

Silent Threat: Delayed Brain Metastasis After Successful Ovarian Cancer Therapy

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Brain metastases from ovarian carcinoma are a rare occurrence, with an incidence rate ranging from 0.49% to 6.1% of cases. These metastases are often associated with a poor prognosis, with a median survival time ranging from 2 to 10 months following diagnosis.
Fatema Hashem Rupa, Mohammad Ashraful Amin   +1 more
wiley   +1 more source

Topical Estradiol Gel Leading to Laboratory Error in Serum Estradiol Measurement: A Diagnostic Pitfall

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Estradiol gel is commonly used as an estrogen replacement therapy for patients with menopausal symptoms. Herein, we present a case of a patient with iatrogenic primary ovarian insufficiency who exhibited an abnormally elevated serum estradiol concentration (5634.0 pg/mL) during routine estradiol monitoring.
Takeki Sato, Masahito Tachibana, Hiroaki Hiraga, Emi Yokoyama, Zen Watanabe, Masatoshi Saito   +5 more
wiley   +1 more source

A Rare Case of Choriocarcinoma With Myometrial Invasion Mimicking Invasive Mole: Case Report

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Gestational trophoblastic neoplasia (GTN) comprises a group of rare tumors arising from placental trophoblastic tissue, including choriocarcinoma and invasive mole. We present a rare case of choriocarcinoma with isolated myometrial invasion in a 30‐year‐old woman with a history of molar pregnancy and term delivery.
Shaghayegh Vandadi, Afsaneh Tehranian, Nasim Zarifi, Akram Seifollahi, Amirhossein Hajialigol   +4 more
wiley   +1 more source

Advancing equity: the urgent need to include trans and gender diverse people in cervical cancer prevention in Australia

Medical Journal of Australia, Volume 223, Issue 7, Page 338-342, October 2025.
Kade Booth, Jamie Bryant, Shiva Chandra, Cristyn Davies, Lucille Kerr, Katie Wynne, Melissa A Carlson, Barrie Shannon, Sav Zwickl, Tamara Butler, Lisa J Whop   +10 more
wiley   +1 more source

Current status and future perspectives of multi‐modal bacteria‐based cancer therapies

Clinical and Translational Medicine, Volume 15, Issue 10, October 2025.
Bacteria exhibit inherent tumour‐targeting capabilities, particularly thriving in hypoxic tumour microenvironments (TMEs) and activating potent anti‐tumour immune responses through pathogen‐associated molecular patterns (PAMPs) and immunomodulation.
Shuai Fan, Siyu Zhu, Wenyu Wang, Yuetong Liu, Yutong Zhou, Hao Li, Bofeng Liu, Qin Xia, Lili Huang, Lei Dong   +9 more
wiley   +1 more source

Do MRI structured reports with FIGO classifications of leiomyomas contain adequate information for clinical decision making?

International Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 398-404, October 2025.
Abstract Objective To evaluate if structured reports (SR) of pelvic magnetic resonance imaging (MRI) scans using the PALM‐COEIN FIGO (the International Federation of Gynecology & Obstetrics) uterine leiomyomas classification (SR‐FIGO) contain adequate information for clinical decision making compared with narrative reports (NR). Methods Three reporting
Laura Tordjman, Haleh Amirian, Alexandra Alvarez, Sara Shir, Julieta Aristizabal, Patricia Castillo, Prasoon Mohan, Stephanie Delgado, Francesco Alessandrino   +8 more
wiley   +1 more source

Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results

International Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 405-414, October 2025.
Abstract Objectives To explore the role of a DNA methylation assay for managing minimally abnormal cervical cancer screening results in a prospective cohort undergoing opportunistic cervical cancer screening. Methods In the cohort of the METHY2 and METHY3 screening studies of women undergoing opportunistic cervical cancer screening, cervical cytology ...
Xiao Shang, Linghua Kong, Yan You, Huanwen Wu, Yuligh Liou, Xitong Jin, Pei Liu, Jinghe Lang, Lei Li   +8 more
wiley   +1 more source

Cancer in pregnancy: FIGO Best practice advice and narrative review

International Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 131-151, October 2025.
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda, Melanie Nana, Long Nguyen‐Hoang, Sumaiya Adam, Fionnuala McAuliffe, Lina Bergman, Sarikapan Wilailak, Orla McNally, Cynthia V. Maxwell, Nikhil Purandare, Bo Jacobsson, Virna P. Medina, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Ernesto Castelazo, Graeme N. Smith, Sharleen L. O'Reilly, Patrick O'Brien, Mark Hanson, Mary L. Rosser, Claudio Sosa, Valerie Guinto, Jonathan Berek, Catherine Nelson‐Piercy, Frédéric Amant, Liona Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health, FIGO Committee on Women's Cancer, and the FIGO Division of Maternal and Newborn Health   +29 more
wiley   +1 more source

Cancer and fertility management: FIGO best practice advice

International Journal of Gynecology &Obstetrics, Volume 171, Issue 1, Page 32-44, October 2025.
Abstract Cancer diagnoses in patients of reproductive age require balancing urgent oncological treatment with the need to preserve fertility. This FIGO Best Practice Advice outlines key considerations for fertility management in this population given the rising cancer incidence among young women and the reproductive risks posed by cancer treatments ...
Nikhil Purandare, Francisco Ruiloba, Long Nguyen‐Hoang, Sarikapan Wilailak, Nozomu Yanaihara, Jacqueline P. W. Chung, Jaideep Malhotra, Edgar Mocanu, Frédéric Amant, Orla McNally, Inge Peters, Katie Flynn, Aya El Helali, Cynthia Maxwell, Sumaiya Adam, Lina Bergman, Surabhi Nanda, Valerie Tiempo Guinto, Fionnuala M. McAuliffe, Catherine Nelson‐Piercy, Melanie Nana, Graeme Smith, Jonathan Berek, Sharleen O'Reilly, Pat O'Brien, Bo Jacobsson, Liona C. Poon, on behalf of the FIGO Committee on the Impact of Pregnancy on Long‐term Health and the FIGO Division of Maternal and Newborn Health and in collaboration with the FIGO Committee on Women's Cancer and the FIGO Committee on Reproductive Medicine, Endocrinology and Infertility   +28 more
wiley   +1 more source

Repurposing the Antidepressant Sertraline: A Systematic Scoping Review of Its Anticancer Mechanisms

Pharmacology Research &Perspectives, Volume 13, Issue 5, October 2025.
A multi‐targeted antidepressant with strong preclinical anticancer activity, sertraline represents a candidate for therapeutic repurposing. ABSTRACT Drug repurposing offers a cost‐effective and time‐efficient strategy for identifying new cancer therapies. Sertraline, a widely prescribed selective serotonin reuptake inhibitor (SSRI), has shown promising
Ciara B. Blum, McCarlie‐Jayne Dohrmann, Lucia McCarthy, Milli McMenamin, Liam A. O'Callaghan   +4 more
wiley   +1 more source